ACTIVATION OF HAGEMAN FACTOR BY SOLUTIONS OF ELLAGIC ACID.
D035843:Biomedical Research; D001779:Blood Coagulation Factors; D002396:Catechols; D004295:Dihydroxyphenylalanine; D004298:Dopamine; D004610:Ellagic Acid; D005168:Factor VII Deficiency; D005174:Factor XII; D005419:Flavonoids; D005707:Gallic Acid; D006467:Hemophilia A; D002836:Hemophilia B; D006801:Humans; D007783:Lactones; D010600:Pharmacology; D011516:Prothrombin; D011748:Pyrogallol; D012106:Research; D012712:Serum Globulins; D013634:Tannins; D013917:Thrombin; D013925:Thromboplastin
D001779:Blood Coagulation Factors; D002396:Catechols; D005419:Flavonoids; D007783:Lactones; D012712:Serum Globulins; D013634:Tannins; D011748:Pyrogallol; D004610:Ellagic Acid; D004295:Dihydroxyphenylalanine; D005707:Gallic Acid; D011516:Prothrombin; D005174:Factor XII; D013925:Thromboplastin; D013917:Thrombin; C034221:catechol; D004298:Dopamine
BIOFLAVONOIDS; BLOOD COAGULATION FACTORS; CATECHOL; CHRISTMAS DISEASE; CLINICAL RESEARCH; DOPA; DOPAMINE; EXPERIMENTAL LAB STUDY; FACTOR XII; GALLIC ACID; HEMOPHILIA; HYPOPROCONVERTINEMIA; LACTONES; PHARMACOLOGY; PROTHROMBIN; PYROGALLOL; SERUM GLOBULINS; TANNINS; THROMBIN; THROMBOPLASTIN